Login

Switch On Your HIV Smarts.

Antibody therapies effective at preventing HIV from invading CD4 cells

Antibody therapies effective at preventing HIV from invading CD4 cells

March 2, 2017, by

Research on two new long-acting antibody therapies demonstrates success at protecting CD4 cells and suppressing viral loads in people living with HIV. Read More

BREAKING NEWS: California cancels contract with ADAP administrator; HIV advocates hopeful for a better system

BREAKING NEWS: California cancels contract with ADAP administrator; HIV advocates hopeful for a better system

March 1, 2017, by

HIV advocates are hopeful that the change will fix the ongoing problems ADAP has experienced, and improve the experience for ADAP clients. Read More

“Dream big, take risks”: How NYC is on the way to ending its AIDS epidemic

“Dream big, take risks”: How NYC is on the way to ending its AIDS epidemic

February 28, 2017, by

New York City is re-imagining its provision of sexual health services with increased access to PrEP, PEP and HIV treatment. Read More

Is this the end of gay bars in San Francisco?

Is this the end of gay bars in San Francisco?

February 27, 2017, by

Cirrus contemplates the “gay” bars appealing to mixed crowds, the changing make-up of the Castro, and the more fluid gender and sexual identities of younger LGBT people. Read More

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

February 24, 2017, by

Two new HIV drugs, an NNRTI and an integrase inhibitor, did well in clinical trials and are currently being tested as part of fixed-dose co-formulated pills. Read More